Copy Number Varia/on Detec/on. Alex Mawla UCD Genome Center Bioinforma5cs Core Tuesday June 16, 2015
|
|
- Drusilla Martin
- 6 years ago
- Views:
Transcription
1 Copy Number Varia/on Detec/on Alex Mawla UCD Genome Center Bioinforma5cs Core Tuesday June 16, 2015
2 Today s Goals Understand the applica5on and capabili5es of using targe5ng sequencing and CNV calling in a clinical or research sekng In today s exercise, you will: Align raw FASTQ reads using Bow5e2 Generate depth of coverage files from BAM files using targetdepth (Samtools depth wrapper) Learn to set parameters and work with input files (bait probe, regions of interest) for the targeted CNV calling tool, PanelDoC Run PanelDoC using R Script on a subset of data and interpret results 2
3 What are CNVs? Copy Number Varia5ons are altera5ons in the genome that result in either normal or abnormal varia5ons in the number of copies of a gene or region Field has been limited in focusing on exome regions of interest, but with decreases in whole genome sequencing cost, non- coding copy number varia5ons are star5ng to be considered 3
4 What are CNVs? (cont d) Structural varia5ons (unbalanced) Duplica5on (gain) Dele5on (loss) AB CDE FG Dele5on AB FG Duplica5on AB CDE CDE FG 4
5 Mechanisms Different causes: Homologous recombina5on can result in tandem repe55on and dele5on of a gene Non- homologous repair can result in dele5ons Non Allelic Homologous Recombination The Fast Car The Brown Rat The Fast Car The Brown Rat X Homologous Recombination at Incorrect Locus The Fast Car The Fast BrownCar Rat The Brown Rat Tandem Duplication The Brown Rat Deletion Non homologous Repair (e.g. NHEJ) Horses Eat Oats Cats Chase Mice DNA break Horses Eat Oats Cats Chase Mice deleted after repair Horses Eat Mice Deletion 5
6 Consequences Consequences include: dosage effect, gain of func5on, or loss of func5on Dosage Effect Loss Protein B 2X Protein B New Alleles Gain of Function Protein A Fusion Protein Protein 6
7 Why care about CNVs? CNVs have been iden5fied as causes to many human diseases: Au5sm (Marshall et al, 2012) Cancer (Walsh et al, 2010) Crohn s Disease (Schaschl et al, 2009) Down Syndrome (Ramachandran et al, 2014) HIV suscep5bility (Hollox et al, 2014) Idiopathic Learning Disability (Morrow et al, 2010) Lupus (Chen et al, 2014) Schizophrenia (Suleyman et al, 2015) 7
8 Why care about CNVs? (cont d) Ex: GSTM1 gene: involved in coding for glutathione What happens during a null dele5on (0 copies)? Individuals with low number of copies are more suscep5ble to certain cancers, but also have a beder clinical outcome (Mahimkar et al., 2012) Ex: CCL3L1 gene: codes protein that binds to the CCR5 binding site on immune cells Individuals with higher number of copies are less suscep5ble to HIV infec5on (Urban et al., 2009) 8
9 Different Sequencing Methods Whole Genome Sequencing Most expensive Sequences coding and non- coding regions of the genome Less used in clinical and research sekngs, but now emerging Exome Sequencing Moderately expensive Sequences all coding regions of the genome 180,000 exons 1% of en5re human genome Oien used in clinical and research sekngs Targeted Sequencing Cheapest Sequences specific regions of interest, usually within exomes Growing amount of use in clinical and research sekngs 9
10 What is Targeted Sequencing? Target Sequencing is the sequencing of specific regions of the genome, usually within the exome, to specifically look at certain areas of interest Magnitudes cheaper than exome or whole genome sequencing Two primary methods: Bait- probe hybridiza5on capture Uses overlapping modified bait probe sequences to capture specific genes of interest Amplicon- based Uses primers 10
11 Bait Probe Hybridiza5on Capture Modified bait probes designed to capture specific regions of interest from the cdna library Usually designed to 5le to ensure strong capture of all nucleo5des in region of interest crna baits (3x 5ling) Area of Interest Repeat 11
12 Different CNV Tools Whole Genome Sequencing Tools SegSeq cnvhmm CNVnator Exome Sequencing Tools CoNIFER XHMM ExomeCNV Targeted Sequencing Tools Svseq SVDetect PanelDoC Reference: Zhao et al,
13 Why PanelDoC? Designed to work well with bait- probe hybridiza5on capture Works with exome sequencing as well Can be used on blood samples, or tumor popula5ons Sensi5ve to small CNVs (31 bp) Very good with larger CNV (>1 kb) detec5on Verified against breast cancer study data Future updates: Complementary hidden markov model will be added to improve robustness Func5onality to handle amplicon- based capture will also be added 13
14 PanelDoC Background Developed by Dr. Alex Nord at University of Washington in 2011 (Nord et al, 2011) Verified by evalua5ng 94 pa5ents for CNVs related to breast and ovarian cancer Correctly iden5fied all known muta5ons Iden5fied 10 CNVs (5 gains and 5 losses) in four cancer- related genes Confirmed a 31 bp homozygous dele5on in BRCA2 Detected 200 bp CNV with 87% sensi5vity and 100 bp CNV with 80% sensi5vity at high signal- to- noise ra5os 14
15 '''''''''''+,++,+-.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+' ''''''''''''',++,+-.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,' ''''''''''''',++,+-.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,' '''''''''''''''''+,+-.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+' ''''''''''''''''''',+-.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..' ''''''''''''''''''',+-.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..' '''''''''''''''''''''+-.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+' '''''''''''''''''''''+-.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+' '''''''''''''''''''''+-.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+' '''''''''''''''''''''''-.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,' '''''''''''''''''''''''-.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,' ''''''''''''''''''''''''''.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' ''''''''''''''''''''''''''.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' '''''''''''''''''''''''''''',-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' '''''''''''''''''''''''''''''''-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' ''''''''''''''''''''''''''''''''''.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' '''''''''''''''''''''''''''''''''''',,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' ''''''''''''''''''''''''''''''''''''''',+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' '''''''''''''''''''''''''''''''''''''''''+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' ''''''''''''''''''''''''''''''''''''''''''',-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' ''''''''''''''''''''''''''''''''''''''''''''''-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' ''''''''''''''''''''''''''''''''''''''''''''''''',+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' '''''''''''''''''''''''''''''''''''''''''''''''''''+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' ''''''''''''''''''''''''''''''''''''''''''''''''''''',,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' '''''''''''''''''''''''''''''''''''''''''''''''''''''''',++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''+-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-'''''''''''''''''''''' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-''''''''''' '''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''',,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-''''''''''''''' '''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''',,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-''''''''''''' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''',.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-'' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' ''''''''''''''''''''''''''''',-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--' '''''''''''''''''''''''''''''''-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.' ''''''''''''''''''''''''''''''''''.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+' '''''''''''''''''''''''''''''''''''',,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,' ''''''''''''''''''''''''''''''''''''''',+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,' '''''''''''''''''''''''''''''''''''''''''+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.' ''''''''''''''''''''''''''''''''''''''''''',-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-' ''''''''''''''''''''''''''''''''''''''''''''''-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,' ''''''''''''''''''''''''''''''''''''''''''''''-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,' ''''''''''''''''''''''''''''''''''''''''''''''''',+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+' '''''''''''''''''''''''''''''''''''''''''''''''''''+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.' ''''''''''''''''''''''''''''''''''''''''''''''''''''',,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.,' '''''''''''''''''''''''''''''''''''''''''''''''''''''''',++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.,.' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.,.-' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.,.-''''''''''''''''''''''''''''''''''''''''''''''''''''''' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''+-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.,.-,''''''' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''+-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.,.-,'' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.,.-,.''' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.,.-,.' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.,.-,.'' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''',,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.,.-,.+''''''' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''',,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.,.-,.+' Methods Pre- PanelDoC Map reads to genome Generate coverage Normalize coverage Sample specific effect GC content bias Bait probe 5ling Call CNVs with sliding window approach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
16 Methods (cont d) Bait- probe hybridiza5on capture used to capture regions of interest at minimum of 50x- 100x depth 16
17 Methods (cont d) Reads can be mapped with aligners such as: BWA Bow5e/Bow5e2 Coverage files can be generated using a tool in the Samtools suite: Samtools depth targetdepth is a wrapper that will automate this process for each region of interest 17
18 PanelDoC Methods Raw depth of coverage is noisy Raw Coverage Example (chr17: ) Coverage Large varia5ons in coverage Processing steps necessary for CNV analysis 1. Coverage normaliza5on & correc5on 2. Analyze rela5ve coverage vs. expected diploid coverage Gaps where repeats are present 18
19 PanelDoC Methods (cont d) Raw coverage is normalized against median coverage per base posi5on across all samples Raw coverage counts from alignment Normaliza5on to median coverage 19
20 PanelDoC Methods (cont d) Normalized coverage is corrected for GC content bias and bait probe 5ling 20
21 PanelDoc Methods (cont d) Bait Probe Tiling Normaliza5on: Overlap will lead to skewed depth of coverage values crna baits (3x 5ling) Area of Interest Repeat 21
22 PanelDoc Methods (cont d) GC content and capture bias correc5on Raw coverage counts from alignment Normaliza5on to median coverage Correc5on for GC and capture bias 22
23 PanelDoc Methods (cont d) Raw coverage counts from alignment Normaliza5on to median coverage Correc5on for GC content and capture bias Rela5ve ra5o calcula5on and QC 23
24 PanelDoc Methods (cont d) CNV called using sliding window algorithm CNV calling 24
25 PanelDoC Applica5on: Breast Cancer 25
26 '''''''''''+,++,+-.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+' ''''''''''''',++,+-.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,' ''''''''''''',++,+-.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,' '''''''''''''''''+,+-.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+' ''''''''''''''''''',+-.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..' ''''''''''''''''''',+-.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..' '''''''''''''''''''''+-.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+' '''''''''''''''''''''+-.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+' '''''''''''''''''''''+-.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+' '''''''''''''''''''''''-.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,' '''''''''''''''''''''''-.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,' ''''''''''''''''''''''''''.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' ''''''''''''''''''''''''''.,-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' '''''''''''''''''''''''''''',-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' '''''''''''''''''''''''''''''''-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' ''''''''''''''''''''''''''''''''''.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' '''''''''''''''''''''''''''''''''''',,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' ''''''''''''''''''''''''''''''''''''''',+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' '''''''''''''''''''''''''''''''''''''''''+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' ''''''''''''''''''''''''''''''''''''''''''',-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' ''''''''''''''''''''''''''''''''''''''''''''''-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' ''''''''''''''''''''''''''''''''''''''''''''''''',+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' '''''''''''''''''''''''''''''''''''''''''''''''''''+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' ''''''''''''''''''''''''''''''''''''''''''''''''''''',,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' '''''''''''''''''''''''''''''''''''''''''''''''''''''''',++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''+-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-'''''''''''''''''''''' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-''''''''''' '''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''',,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-''''''''''''''' '''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''',,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-''''''''''''' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''',.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-'' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,-' ''''''''''''''''''''''''''''',-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--' '''''''''''''''''''''''''''''''-.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.' ''''''''''''''''''''''''''''''''''.,,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+' '''''''''''''''''''''''''''''''''''',,+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,' ''''''''''''''''''''''''''''''''''''''',+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,' '''''''''''''''''''''''''''''''''''''''''+,-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.' ''''''''''''''''''''''''''''''''''''''''''',-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-' ''''''''''''''''''''''''''''''''''''''''''''''-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,' ''''''''''''''''''''''''''''''''''''''''''''''-,+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,' ''''''''''''''''''''''''''''''''''''''''''''''''',+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+' '''''''''''''''''''''''''''''''''''''''''''''''''''+,,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.' ''''''''''''''''''''''''''''''''''''''''''''''''''''',,++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.,' '''''''''''''''''''''''''''''''''''''''''''''''''''''''',++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.,.' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.,.-' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''++-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.,.-''''''''''''''''''''''''''''''''''''''''''''''''''''''' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''+-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.,.-,''''''' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''+-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.,.-,'' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.,.-,.''' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.,.-,.' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''-,,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.,.-,.'' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''',,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.,.-,.+''''''' ''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''',,,,.,,++,+..,-..,--+-., ,.,..+-+,,+.+.,-.-,+.+,+..+,--.+,,.-,+.,.-,.+' Methods: Review Pre- PanelDoC Map reads to genome Generate coverage Normalize coverage Sample specific effect GC content bias Bait probe 5ling Call CNVs with sliding window approach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
27 Exercise Goals In today s exercise, you will: Align raw FASTQ reads using Bow5e2 Generate depth of coverage from BAM files using targetdepth Learn to set parameters and work with input files (bait probe, regions of interest) in PanelDoC Run PanelDoC through R Script on a subset of data and interpret results 27
28 Acknowledgements Dr. Alex Nord UCD Genome Center Bioinforma5cs Core Team Dr. Monica Bridon Dr. Joseph Fass Dr. Nikhil Joshi Dr. Ian Korf 28
29 Ques5ons? 29
Abstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction
Optimization strategy of Copy Number Variant calling using Multiplicom solutions Michael Vyverman, PhD; Laura Standaert, PhD and Wouter Bossuyt, PhD Abstract Copy number variations (CNVs) represent a significant
More informationUsing the Bravo Liquid-Handling System for Next Generation Sequencing Sample Prep
Using the Bravo Liquid-Handling System for Next Generation Sequencing Sample Prep Tom Walsh, PhD Division of Medical Genetics University of Washington Next generation sequencing Sanger sequencing gold
More informationDNA-seq Bioinformatics Analysis: Copy Number Variation
DNA-seq Bioinformatics Analysis: Copy Number Variation Elodie Girard elodie.girard@curie.fr U900 institut Curie, INSERM, Mines ParisTech, PSL Research University Paris, France NGS Applications 5C HiC DNA-seq
More informationBreast and ovarian cancer in Serbia: the importance of mutation detection in hereditary predisposition genes using NGS
Breast and ovarian cancer in Serbia: the importance of mutation detection in hereditary predisposition genes using NGS dr sc. Ana Krivokuća Laboratory for molecular genetics Institute for Oncology and
More informationCopy Number Variations and Association Mapping Advanced Topics in Computa8onal Genomics
Copy Number Variations and Association Mapping 02-715 Advanced Topics in Computa8onal Genomics SNP and CNV Genotyping SNP genotyping assumes two copy numbers at each locus (i.e., no CNVs) CNV genotyping
More informationMultiplex target enrichment using DNA indexing for ultra-high throughput variant detection
Multiplex target enrichment using DNA indexing for ultra-high throughput variant detection Dr Elaine Kenny Neuropsychiatric Genetics Research Group Institute of Molecular Medicine Trinity College Dublin
More informationNGS, Cancer and Bioinforma;cs. 20/10/15 Yannick Boursin
NGS, Cancer and Bioinforma;cs 1 NGS and Clinical Oncology NGS in hereditary cancer genome tes;ng BRCA1/2 (breast/ovary cancer) XPC (melanoma) ERCC1 (colorectal cancer) NGS for personalized cancer treatment
More informationCharacterisation of structural variation in breast. cancer genomes using paired-end sequencing on. the Illumina Genome Analyser
Characterisation of structural variation in breast cancer genomes using paired-end sequencing on the Illumina Genome Analyser Phil Stephens Cancer Genome Project Why is it important to study cancer? Why
More informationCanadian Bioinforma1cs Workshops
5/12/16 Canadian Bioinforma1cs Workshops www.bioinforma1cs.ca Module #: Title of Module 2 1 Module 3 Introduc1on to WGBS and analysis Guillaume Bourque Learning Objec/ves of Module Know the different technologies
More informationCalling DNA variants SNVs, CNVs, and SVs. Steve Laurie Variant Effect Predictor Training Course Prague, 6 th November 2017
1 Calling DNA variants SNVs, CNVs, and SVs Steve Laurie Variant Effect Predictor Training Course Prague, 6 th November 2017 Calling DNA variants SNVs, CNVs, SVs 2 1. What is a variant? 2. Paired End read
More informationAdvance Your Genomic Research Using Targeted Resequencing with SeqCap EZ Library
Advance Your Genomic Research Using Targeted Resequencing with SeqCap EZ Library Marilou Wijdicks International Product Manager Research For Life Science Research Only. Not for Use in Diagnostic Procedures.
More informationAVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits
AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits Accelerating clinical research Next-generation sequencing (NGS) has the ability to interrogate many different genes and detect
More informationEvolu&on of Disease genes
Evolu&on of Disease genes Many human diseases are caused by muta1ons in single genes A synthe&c pathway and associated diseases Autosomal dominant condi&ons Dominant Disorders A single mutant gene is sufficient
More informationGlobal variation in copy number in the human genome
Global variation in copy number in the human genome Redon et. al. Nature 444:444-454 (2006) 12.03.2007 Tarmo Puurand Study 270 individuals (HapMap collection) Affymetrix 500K Whole Genome TilePath (WGTP)
More informationAnalysis with SureCall 2.1
Analysis with SureCall 2.1 Danielle Fletcher Field Application Scientist July 2014 1 Stages of NGS Analysis Primary analysis, base calling Control Software FASTQ file reads + quality 2 Stages of NGS Analysis
More informationEvolu+on of Disease genes
Evolu+on of Disease genes Many human diseases are caused by muta1ons in single genes 1 A synthe+c pathway and associated diseases Autosomal dominant condi+ons 2 Dominant Disorders A single mutant gene
More informationTranscript reconstruction
Transcript reconstruction Summary I Data types, file formats and utilities Annotation: Genomic regions Genes Peaks bedtools Alignment: Map reads BAM/SAM Samtools Aggregation: Summary files Wig (UCSC) TDF
More informationGenomic structural variation
Genomic structural variation Mario Cáceres The new genomic variation DNA sequence differs across individuals much more than researchers had suspected through structural changes A huge amount of structural
More informationcn.mops - Mixture of Poissons for CNV detection in NGS data Günter Klambauer Institute of Bioinformatics, Johannes Kepler University Linz
Software Manual Institute of Bioinformatics, Johannes Kepler University Linz cn.mops - Mixture of Poissons for CNV detection in NGS data Günter Klambauer Institute of Bioinformatics, Johannes Kepler University
More informationCharacteriza*on of Soma*c Muta*ons in Cancer Genomes
Characteriza*on of Soma*c Muta*ons in Cancer Genomes Ben Raphael Department of Computer Science Center for Computa*onal Molecular Biology Soma*c Muta*ons and Cancer Clonal Theory (Nowell 1976) Passenger
More informationRecombina*on of Linked Genes: Crossing Over. discovered that genes can be linked. the linkage was incomplete
Recombina*on of Linked Genes: Crossing Over Fig. 15-10 Testcross parents Gray body, normal wings (F 1 dihybrid) Black body, vestigial wings (double mutant) Morgan discovered that genes can be linked the
More informationcn.mops - Mixture of Poissons for CNV detection in NGS data Günter Klambauer Institute of Bioinformatics, Johannes Kepler University Linz
Software Manual Institute of Bioinformatics, Johannes Kepler University Linz cn.mops - Mixture of Poissons for CNV detection in NGS data Günter Klambauer Institute of Bioinformatics, Johannes Kepler University
More informationCytogenetics 101: Clinical Research and Molecular Genetic Technologies
Cytogenetics 101: Clinical Research and Molecular Genetic Technologies Topics for Today s Presentation 1 Classical vs Molecular Cytogenetics 2 What acgh? 3 What is FISH? 4 What is NGS? 5 How can these
More informationMissing Heritablility How to Analyze Your Own Genome Fall 2013
Missing Heritablility 02-223 How to Analyze Your Own Genome Fall 2013 Heritability Heritability: the propor>on of observed varia>on in a par>cular trait (as height) that can be agributed to inherited gene>c
More informationGenome-wide copy-number calling (CNAs not CNVs!) Dr Geoff Macintyre
Genome-wide copy-number calling (CNAs not CNVs!) Dr Geoff Macintyre Structural variation (SVs) Copy-number variations C Deletion A B C Balanced rearrangements A B A B C B A C Duplication Inversion Causes
More informationNGS in Cancer Pathology After the Microscope: From Nucleic Acid to Interpretation
NGS in Cancer Pathology After the Microscope: From Nucleic Acid to Interpretation Michael R. Rossi, PhD, FACMG Assistant Professor Division of Cancer Biology, Department of Radiation Oncology Department
More informationCNV Detection and Interpretation in Genomic Data
CNV Detection and Interpretation in Genomic Data Benjamin W. Darbro, M.D., Ph.D. Assistant Professor of Pediatrics Director of the Shivanand R. Patil Cytogenetics and Molecular Laboratory Overview What
More informationSmall RNAs and how to analyze them using sequencing
Small RNAs and how to analyze them using sequencing Jakub Orzechowski Westholm (1) Long- term bioinforma=cs support, Science For Life Laboratory Stockholm (2) Department of Biophysics and Biochemistry,
More informationCNV detection. Introduction and detection in NGS data. G. Demidov 1,2. NGSchool2016. Centre for Genomic Regulation. CNV detection. G.
Introduction and detection in NGS data 1,2 1 Genomic and Epigenomic Variation in Disease group, Centre for Genomic Regulation 2 Universitat Pompeu Fabra NGSchool2016 methods: methods Outline methods: methods
More informationAndrew Parrish, Richard Caswell, Garan Jones, Christopher M. Watson, Laura A. Crinnion 3,4, Sian Ellard 1,2
METHOD ARTICLE An enhanced method for targeted next generation sequencing copy number variant detection using ExomeDepth [version 1; referees: 1 approved, 1 approved with reservations] 1 2 1 3,4 Andrew
More informationInvestigating rare diseases with Agilent NGS solutions
Investigating rare diseases with Agilent NGS solutions Chitra Kotwaliwale, Ph.D. 1 Rare diseases affect 350 million people worldwide 7,000 rare diseases 80% are genetic 60 million affected in the US, Europe
More informationGenetic Tests and Genetic Counseling How to Analyze Your Own Genome
Genetic Tests and Genetic Counseling 02-223 How to Analyze Your Own Genome Genetic Tests for Huntington Disease Hun7ngton Disease Incurable brain disorder that runs in families Movement, cogni7ve, and
More informationMutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research
Mutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research Application Note Authors John McGuigan, Megan Manion,
More informationEmerging gene)cs in schizophrenia: Real challenges for crea)ng animal models
Emerging gene)cs in schizophrenia: Real challenges for crea)ng animal models Steven A McCarroll, PhD Stanley Center for Psychiatric Research, Broad Ins7tute Department of Gene7cs, Harvard Medical School
More informationDetection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit
APPLICATION NOTE Ion PGM System Detection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit Key findings The Ion PGM System, in concert with the Ion ReproSeq PGS View Kit and Ion Reporter
More informationConsidera*ons when undergoing personal genotyping
Considera*ons when undergoing personal genotyping Kelly Ormond, MS, CGC Louanne Hudgins, MD, FACMG January 19, 2011 GENE 210 Disclosures and introduc*ons Professor Ormond provided paid consulta*on for
More informationNature Genetics: doi: /ng Supplementary Figure 1. PCA for ancestry in SNV data.
Supplementary Figure 1 PCA for ancestry in SNV data. (a) EIGENSTRAT principal-component analysis (PCA) of SNV genotype data on all samples. (b) PCA of only proband SNV genotype data. (c) PCA of SNV genotype
More informationGenerating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University
Role of Chemical lexposure in Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University CNV Discovery Reference Genetic
More informationWhole Genome and Transcriptome Analysis of Anaplastic Meningioma. Patrick Tarpey Cancer Genome Project Wellcome Trust Sanger Institute
Whole Genome and Transcriptome Analysis of Anaplastic Meningioma Patrick Tarpey Cancer Genome Project Wellcome Trust Sanger Institute Outline Anaplastic meningioma compared to other cancers Whole genomes
More informationPERSONALIZED GENETIC REPORT CLIENT-REPORTED DATA PURPOSE OF THE X-SCREEN TEST
INCLUDED IN THIS REPORT: REVIEW OF YOUR GENETIC INFORMATION RELEVANT TO ENDOMETRIOSIS PERSONAL EDUCATIONAL INFORMATION RELEVANT TO YOUR GENES INFORMATION FOR OBTAINING YOUR ENTIRE X-SCREEN DATA FILE PERSONALIZED
More informationAgilent s Copy Number Variation (CNV) Portfolio
Technical Overview Agilent s Copy Number Variation (CNV) Portfolio Abstract Copy Number Variation (CNV) is now recognized as a prevalent form of structural variation in the genome contributing to human
More informationSupplementary Figure 1
Supplementary Figure 1 Supplementary Fig. 1: Quality assessment of formalin-fixed paraffin-embedded (FFPE)-derived DNA and nuclei. (a) Multiplex PCR analysis of unrepaired and repaired bulk FFPE gdna from
More informationChIP-seq hands-on. Iros Barozzi, Campus IFOM-IEO (Milan) Saverio Minucci, Gioacchino Natoli Labs
ChIP-seq hands-on Iros Barozzi, Campus IFOM-IEO (Milan) Saverio Minucci, Gioacchino Natoli Labs Main goals Becoming familiar with essential tools and formats Visualizing and contextualizing raw data Understand
More informationDNA Sequence Bioinformatics Analysis with the Galaxy Platform
DNA Sequence Bioinformatics Analysis with the Galaxy Platform University of São Paulo, Brazil 28 July - 1 August 2014 Dave Clements Johns Hopkins University Robson Francisco de Souza University of São
More informationncounter Data Analysis Guidelines for Copy Number Variation (CNV) Molecules That Count NanoString Technologies, Inc.
ncounter Data Analysis Guidelines for Copy Number Variation (CNV) NanoString Technologies, Inc. 530 Fairview Ave N Suite 2000 Seattle, Washington 98109 www.nanostring.com Tel: 206.378.6266 888.358.6266
More informationACE ImmunoID Biomarker Discovery Solutions ACE ImmunoID Platform for Tumor Immunogenomics
ACE ImmunoID Biomarker Discovery Solutions ACE ImmunoID Platform for Tumor Immunogenomics Precision Genomics for Immuno-Oncology Personalis, Inc. ACE ImmunoID When one biomarker doesn t tell the whole
More informationCarcinoma mammario triple nega0ve Nuove acquisizioni biologiche. Giuseppe Curigliano MD PhD UNIMI & IEO
Carcinoma mammario triple nega0ve Nuove acquisizioni biologiche Giuseppe Curigliano MD PhD UNIMI & IEO Outline San Antonio Breast Cancer Symposium, December 5-9, 2017 The year of DNA Repair targe?ng Olaparib
More informationSUPPLEMENTARY INFORMATION
doi: 1.138/nature8645 Physical coverage (x haploid genomes) 11 6.4 4.9 6.9 6.7 4.4 5.9 9.1 7.6 125 Neither end mapped One end mapped Chimaeras Correct Reads (million ns) 1 75 5 25 HCC1187 HCC1395 HCC1599
More informationBiosta's'cs Board Review. Parul Chaudhri, DO Family Medicine Faculty Development Fellow, UPMC St Margaret March 5, 2016
Biosta's'cs Board Review Parul Chaudhri, DO Family Medicine Faculty Development Fellow, UPMC St Margaret March 5, 2016 Review key biosta's'cs concepts Understand 2 X 2 tables Objec'ves By the end of this
More informationMolEcular Taxonomy of BReast cancer International Consortium (METABRIC)
PERSPECTIVE 1 LARGE SCALE DATASET EXAMPLES MolEcular Taxonomy of BReast cancer International Consortium (METABRIC) BC Cancer Agency, Vancouver Samuel Aparicio, PhD FRCPath Nan and Lorraine Robertson Chair
More informationIdentifying Mutations Responsible for Rare Disorders Using New Technologies
Identifying Mutations Responsible for Rare Disorders Using New Technologies Jacek Majewski, Department of Human Genetics, McGill University, Montreal, QC Canada Mendelian Diseases Clear mode of inheritance
More informationNature Biotechnology: doi: /nbt.1904
Supplementary Information Comparison between assembly-based SV calls and array CGH results Genome-wide array assessment of copy number changes, such as array comparative genomic hybridization (acgh), is
More informationPerformance Characteristics BRCA MASTR Plus Dx
Performance Characteristics BRCA MASTR Plus Dx with drmid Dx for Illumina NGS systems Manufacturer Multiplicom N.V. Galileïlaan 18 2845 Niel Belgium Table of Contents 1. Workflow... 4 2. Performance Characteristics
More informationRNA SEQUENCING AND DATA ANALYSIS
RNA SEQUENCING AND DATA ANALYSIS Download slides and package http://odin.mdacc.tmc.edu/~rverhaak/package.zip http://odin.mdacc.tmc.edu/~rverhaak/rna-seqlecture.zip Overview Introduction into the topic
More informationRNA SEQUENCING AND DATA ANALYSIS
RNA SEQUENCING AND DATA ANALYSIS Length of mrna transcripts in the human genome 5,000 5,000 4,000 3,000 2,000 4,000 1,000 0 0 200 400 600 800 3,000 2,000 1,000 0 0 2,000 4,000 6,000 8,000 10,000 Length
More informationP. Tang ( 鄧致剛 ); PJ Huang ( 黄栢榕 ) g( ); g ( ) Bioinformatics Center, Chang Gung University.
Databases and Tools for High Throughput Sequencing Analysis P. Tang ( 鄧致剛 ); PJ Huang ( 黄栢榕 ) g( ); g ( ) Bioinformatics Center, Chang Gung University. HTseq Platforms Applications on Biomedical Sciences
More informationDr Rick Tearle Senior Applications Specialist, EMEA Complete Genomics Complete Genomics, Inc.
Dr Rick Tearle Senior Applications Specialist, EMEA Complete Genomics Topics Overview of Data Processing Pipeline Overview of Data Files 2 DNA Nano-Ball (DNB) Read Structure Genome : acgtacatgcattcacacatgcttagctatctctcgccag
More informationCRISPR/Cas9 Enrichment and Long-read WGS for Structural Variant Discovery
CRISPR/Cas9 Enrichment and Long-read WGS for Structural Variant Discovery PacBio CoLab Session October 20, 2017 For Research Use Only. Not for use in diagnostics procedures. Copyright 2017 by Pacific Biosciences
More informationPGC Worldwide Lab Call Details
PGC Worldwide Lab Call Details DATE: Friday, March 15 th, 2013 PRESENTER: Shaun Purcell, Mt Sinai School of Medicine, NYC TITLE: An overview of sequencing studies and their application to psychiatric disease
More informationImplementation of BRCA Oncomine panel for germline and somatic variant analysis
Tagliafico ESHG 2017.pptm 3.2% 03/03/2017 Implementation of BRCA Oncomine panel for germline and somatic variant analysis Enrico Tagliafico MD, PhD, Modena, Italy Center for Genome Research University
More informationSupplementary Tables. Supplementary Figures
Supplementary Files for Zehir, Benayed et al. Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients Supplementary Tables Supplementary Table 1: Sample
More informationIlluminating the genetics of complex human diseases
Illuminating the genetics of complex human diseases Michael Schatz Sept 27, 2012 Beyond the Genome @mike_schatz / #BTG2012 Outline 1. De novo mutations in human diseases 1. Autism Spectrum Disorder 2.
More informationDetection of copy number variations in PCR-enriched targeted sequencing data
Detection of copy number variations in PCR-enriched targeted sequencing data German Demidov Parseq Lab, Saint-Petersburg University of Russian Academy of Sciences, current: Center for Genomic Regulation
More informationChip Seq Peak Calling in Galaxy
Chip Seq Peak Calling in Galaxy Chris Seward PowerPoint by Pei-Chen Peng Chip-Seq Peak Calling in Galaxy Chris Seward 2018 1 Introduction This goals of the lab are as follows: 1. Gain experience using
More informationVariations in Chromosome Structure & Function. Ch. 8
Variations in Chromosome Structure & Function Ch. 8 1 INTRODUCTION! Genetic variation refers to differences between members of the same species or those of different species Allelic variations are due
More informationIntroduction to LOH and Allele Specific Copy Number User Forum
Introduction to LOH and Allele Specific Copy Number User Forum Jonathan Gerstenhaber Introduction to LOH and ASCN User Forum Contents 1. Loss of heterozygosity Analysis procedure Types of baselines 2.
More informationValida5on of a Microsatellite Instability Assay by NGS
Valida5on of a Microsatellite Instability Assay by NGS Mark R. Miglarese, Ph.D. VP R&D 1 Caris Life Sciences 230,000+ tests performed in 2016 Headquarters: Irving, Texas Laboratory: Phoenix, Arizona 66,000
More informationIdentification of regions with common copy-number variations using SNP array
Identification of regions with common copy-number variations using SNP array Agus Salim Epidemiology and Public Health National University of Singapore Copy Number Variation (CNV) Copy number alteration
More informationNext Generation Sequencing as a tool for breakpoint analysis in rearrangements of the globin-gene clusters
Next Generation Sequencing as a tool for breakpoint analysis in rearrangements of the globin-gene clusters XXXth International Symposium on Technical Innovations in Laboratory Hematology Honolulu, Hawaii
More informationAVENIO ctdna Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB
Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB Analysis Kits Next-generation performance in liquid biopsies 2 Accelerating clinical research From liquid biopsy to next-generation
More informationStatistical Applications in Genetics and Molecular Biology
Statistical Applications in Genetics and Molecular Biology Volume 10, Issue 1 2011 Article 52 Modeling Read Counts for CNV Detection in Exome Sequencing Data Michael I. Love, Max Planck Institute for Molecular
More informationPREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland
AD Award Number: W81XWH-12-1-0298 TITLE: MTHFR Functional Polymorphism C677T and Genomic Instability in the Etiology of Idiopathic Autism in Simplex Families PRINCIPAL INVESTIGATOR: Xudong Liu, PhD CONTRACTING
More informationRNA- seq Introduc1on. Promises and pi7alls
RNA- seq Introduc1on Promises and pi7alls DNA is the same in all cells but which RNAs that is present is different in all cells There is a wide variety of different func1onal RNAs Which RNAs (and some1mes
More informationAnalysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers
Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers Gordon Blackshields Senior Bioinformatician Source BioScience 1 To Cancer Genetics Studies
More informationFluxion Biosciences and Swift Biosciences Somatic variant detection from liquid biopsy samples using targeted NGS
APPLICATION NOTE Fluxion Biosciences and Swift Biosciences OVERVIEW This application note describes a robust method for detecting somatic mutations from liquid biopsy samples by combining circulating tumor
More informationCOMPARISON OF HIV DRUG-RESISTANT MUTANT DETECTION BY NGS WITH AND WITHOUT UNIQUE MOLECULAR IDENTIFIERS (UMI)
COMPARISON OF HIV DRUG-RESISTANT MUTANT DETECTION BY NGS WITH AND WITHOUT UNIQUE MOLECULAR IDENTIFIERS (UMI) Kevin D McCormick; Kerri J Penrose; Rahil Sethi; Jacob Waldman; William Schwarzmann; Uma Chandran;
More informationDNA Basics. We are all made up of cells. Cells contain DNA, or instructions to tell our bodies how to work.
DNA Basics We are all made up of cells. Cells contain DNA, or instructions to tell our bodies how to work. DNA is packaged into structures called chromosomes. Each chromosome contains many genes and each
More informationLEIDEN, THE NETHERLANDS
Full-length CYP2D6 diplotyping for better drug dosage and response management Henk Buermans, PhD Leiden University Medical Center Human Genetics, LGTC LEIDEN, THE NETHERLANDS CYP2D6 Function Metabolism
More informationSingle-strand DNA library preparation improves sequencing of formalin-fixed and paraffin-embedded (FFPE) cancer DNA
www.impactjournals.com/oncotarget/ Oncotarget, Supplementary Materials 2016 Single-strand DNA library preparation improves sequencing of formalin-fixed and paraffin-embedded (FFPE) DNA Supplementary Materials
More informationGinkgo Interactive analysis and quality assessment of single-cell CNV data
Ginkgo Interactive analysis and quality assessment of single-cell CNV data @RobAboukhalil Robert Aboukhalil, Tyler Garvin, Jude Kendall, Timour Baslan, Gurinder S. Atwal, Jim Hicks, Michael Wigler, Michael
More informationNo mutations were identified.
Hereditary High Cholesterol Test ORDERING PHYSICIAN PRIMARY CONTACT SPECIMEN Report date: Aug 1, 2017 Dr. Jenny Jones Sample Medical Group 123 Main St. Sample, CA Kelly Peters Sample Medical Group 123
More informationEXAMPLE. - Potentially responsive to PI3K/mTOR and MEK combination therapy or mtor/mek and PKC combination therapy. ratio (%)
Dr Kate Goodhealth Goodhealth Medical Clinic 123 Address Road SUBURBTOWN NSW 2000 Melanie Citizen Referring Doctor Your ref Address Dr John Medico 123 Main Street, SUBURBTOWN NSW 2000 Phone 02 9999 9999
More informationSta$s$cs is Easy. Dennis Shasha From a book co- wri7en with Manda Wilson
Sta$s$cs is Easy Dennis Shasha From a book co- wri7en with Manda Wilson Is the Coin Fair? You toss a coin 17 $mes and it comes up heads 15 out of 17 $mes. How likely is it that coin is fair? Could look
More informationSupplementary Figure 1. Schematic diagram of o2n-seq. Double-stranded DNA was sheared, end-repaired, and underwent A-tailing by standard protocols.
Supplementary Figure 1. Schematic diagram of o2n-seq. Double-stranded DNA was sheared, end-repaired, and underwent A-tailing by standard protocols. A-tailed DNA was ligated to T-tailed dutp adapters, circularized
More informationNGS for Cancer Predisposition
NGS for Cancer Predisposition Colin Pritchard MD, PhD University of Washington Dept. of Lab Medicine AMP Companion Society Meeting USCAP Boston March 22, 2015 Disclosures I am an employee of the University
More informationTowards Personalized Medicine: An Improved De Novo Assembly Procedure for Early Detection of Drug Resistant HIV Minor Quasispecies in Patient Samples
www.bioinformation.net Volume 14(8) Software Model Towards Personalized Medicine: An Improved De Novo Assembly Procedure for Early Detection of Drug Resistant HIV Minor Quasispecies in Patient Samples
More informationHands-On Ten The BRCA1 Gene and Protein
Hands-On Ten The BRCA1 Gene and Protein Objective: To review transcription, translation, reading frames, mutations, and reading files from GenBank, and to review some of the bioinformatics tools, such
More informationCase 1B. 46,XY,-14,+t(14;21)
Case 1B 46,XY,-14,+t(14;21) G-banded Chromosome telomere centromere G-dark bands AT-rich few genes G-pale bands GC-rich many genes telomere ideograms ideograms Conventional (light microscopy) p = short
More informationACE ImmunoID. ACE ImmunoID. Precision immunogenomics. Precision Genomics for Immuno-Oncology
ACE ImmunoID ACE ImmunoID Precision immunogenomics Precision Genomics for Immuno-Oncology Personalis, Inc. A universal biomarker platform for immuno-oncology Patient response to cancer immunotherapies
More informationIdentification of genomic alterations in cervical cancer biopsies by exome sequencing
Chapter- 4 Identification of genomic alterations in cervical cancer biopsies by exome sequencing 105 4.1 INTRODUCTION Athough HPV has been identified as the prime etiological factor for cervical cancer,
More informationPSSV User Manual (V1.0)
PSSV User Manual (V1.0) 1. Introduction A novel pattern-based probabilistic approach, PSSV, is developed to identify somatic structural variations from WGS data. Specifically, discordant and concordant
More informationAssociation mapping (qualitative) Association scan, quantitative. Office hours Wednesday 3-4pm 304A Stanley Hall. Association scan, qualitative
Association mapping (qualitative) Office hours Wednesday 3-4pm 304A Stanley Hall Fig. 11.26 Association scan, qualitative Association scan, quantitative osteoarthritis controls χ 2 test C s G s 141 47
More informationDe novo iden)fica)on of SNPs from RNA- seq data in non- model species
De novo iden)fica)on of SNPs from RNA- seq data in non- model species Hélène Lopez- Maestre 8th Novembre 2016 Why work with RNAseq? Lower cost SNPs from expressed regions SNPs with a more direct func:onal
More informationGolden Helix s End-to-End Solution for Clinical Labs
Golden Helix s End-to-End Solution for Clinical Labs Steven Hystad - Field Application Scientist Nathan Fortier Senior Software Engineer 20 most promising Biotech Technology Providers Top 10 Analytics
More informationAssociating Copy Number and SNP Variation with Human Disease. Autism Segmental duplication Neurobehavioral, includes social disability
Technical Note Associating Copy Number and SNP Variation with Human Disease Abstract The Genome-Wide Human SNP Array 6.0 is an affordable tool to examine the role of copy number variation in disease by
More informationBWA alignment to reference transcriptome and genome. Convert transcriptome mappings back to genome space
Whole genome sequencing Whole exome sequencing BWA alignment to reference transcriptome and genome Convert transcriptome mappings back to genome space genomes Filter on MQ, distance, Cigar string Annotate
More informationMRC-Holland MLPA. Description version 18; 09 September 2015
SALSA MLPA probemix P090-A4 BRCA2 Lot A4-0715, A4-0714, A4-0314, A4-0813, A4-0712: Compared to lot A3-0710, the 88 and 96 nt control fragments have been replaced (QDX2). This product is identical to the
More informationRESISTANCE RELATIONSHIPS BETWEEN PLATINUM AND PARP-INHIBITORS IN OVARIAN CANCER.
RESISTANCE RELATIONSHIPS BETWEEN PLATINUM AND PARP-INHIBITORS IN OVARIAN CANCER. Britta Stordal 1, Yidong Chen 2, Angela Farrelly 3, Danielle Gallagher 3, Steven Busschots 1, Mattia Cremona 3, Mark Carey
More informationp.r623c p.p976l p.d2847fs p.t2671 p.d2847fs p.r2922w p.r2370h p.c1201y p.a868v p.s952* RING_C BP PHD Cbp HAT_KAT11
ARID2 p.r623c KMT2D p.v650fs p.p976l p.r2922w p.l1212r p.d1400h DNA binding RFX DNA binding Zinc finger KMT2C p.a51s p.d372v p.c1103* p.d2847fs p.t2671 p.d2847fs p.r4586h PHD/ RING DHHC/ PHD PHD FYR N
More informationUnderstanding DNA Copy Number Data
Understanding DNA Copy Number Data Adam B. Olshen Department of Epidemiology and Biostatistics Helen Diller Family Comprehensive Cancer Center University of California, San Francisco http://cc.ucsf.edu/people/olshena_adam.php
More information